192 related articles for article (PubMed ID: 18829308)
21. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ
Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500
[TBL] [Abstract][Full Text] [Related]
22. High-throughput X-ray crystallography for drug discovery.
Blundell TL; Patel S
Curr Opin Pharmacol; 2004 Oct; 4(5):490-6. PubMed ID: 15351354
[TBL] [Abstract][Full Text] [Related]
23. Simulations of a G protein-coupled receptor homology model predict dynamic features and a ligand binding site.
Wolf S; Böckmann M; Höweler U; Schlitter J; Gerwert K
FEBS Lett; 2008 Oct; 582(23-24):3335-42. PubMed ID: 18775703
[TBL] [Abstract][Full Text] [Related]
24. X-ray crystallography in drug discovery.
Carvalho AL; Trincão J; Romão MJ
Methods Mol Biol; 2009; 572():31-56. PubMed ID: 20694684
[TBL] [Abstract][Full Text] [Related]
25. Structure-based discovery of beta2-adrenergic receptor ligands.
Kolb P; Rosenbaum DM; Irwin JJ; Fung JJ; Kobilka BK; Shoichet BK
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6843-8. PubMed ID: 19342484
[TBL] [Abstract][Full Text] [Related]
26. The structure of active opsin as a basis for identification of GPCR agonists by dynamic homology modelling and virtual screening assays.
Schneider M; Wolf S; Schlitter J; Gerwert K
FEBS Lett; 2011 Nov; 585(22):3587-92. PubMed ID: 22027616
[TBL] [Abstract][Full Text] [Related]
27. Intramolecular hydrogen bonding in medicinal chemistry.
Kuhn B; Mohr P; Stahl M
J Med Chem; 2010 Mar; 53(6):2601-11. PubMed ID: 20175530
[TBL] [Abstract][Full Text] [Related]
28. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
Reynolds KA; Katritch V; Abagyan R
J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
[TBL] [Abstract][Full Text] [Related]
29. Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors.
Moreau F; Desroy N; Genevard JM; Vongsouthi V; Gerusz V; Le Fralliec G; Oliveira C; Floquet S; Denis A; Escaich S; Wolf K; Busemann M; Aschenbrenner A
Bioorg Med Chem Lett; 2008 Jul; 18(14):4022-6. PubMed ID: 18571407
[TBL] [Abstract][Full Text] [Related]
30. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, bioactivity, theoretical and molecular docking study of 1-cyano-N-substituted-cyclopropanecarboxamide as ketol-acid reductoisomerase inhibitor.
Liu XH; Chen PQ; Wang BL; Li YH; Wang SH; Li ZM
Bioorg Med Chem Lett; 2007 Jul; 17(13):3784-8. PubMed ID: 17512731
[TBL] [Abstract][Full Text] [Related]
32. Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor design.
Liang GB; Qian X; Biftu T; Singh S; Gao YD; Scapin G; Patel S; Leiting B; Patel R; Wu J; Zhang X; Thornberry NA; Weber AE
Bioorg Med Chem Lett; 2008 Jul; 18(13):3706-10. PubMed ID: 18524582
[TBL] [Abstract][Full Text] [Related]
33. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
[TBL] [Abstract][Full Text] [Related]
34. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise.
Yarnitzky T; Levit A; Niv MY
Curr Opin Drug Discov Devel; 2010 May; 13(3):317-25. PubMed ID: 20443165
[TBL] [Abstract][Full Text] [Related]
35. A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design.
Sanders MP; Roumen L; van der Horst E; Lane JR; Vischer HF; van Offenbeek J; de Vries H; Verhoeven S; Chow KY; Verkaar F; Beukers MW; McGuire R; Leurs R; Ijzerman AP; de Vlieg J; de Esch IJ; Zaman GJ; Klomp JP; Bender A; de Graaf C
J Med Chem; 2012 Jun; 55(11):5311-25. PubMed ID: 22563707
[TBL] [Abstract][Full Text] [Related]
36. Macrocyclic peptidomimetic inhibitors of beta-secretase (BACE): first X-ray structure of a macrocyclic peptidomimetic-BACE complex.
Rojo I; Martín JA; Broughton H; Timm D; Erickson J; Yang HC; McCarthy JR
Bioorg Med Chem Lett; 2006 Jan; 16(1):191-5. PubMed ID: 16249081
[TBL] [Abstract][Full Text] [Related]
37. CH/π hydrogen bonds play a role in ligand recognition and equilibrium between active and inactive states of the β2 adrenergic receptor: an ab initio fragment molecular orbital (FMO) study.
Ozawa T; Okazaki K; Kitaura K
Bioorg Med Chem; 2011 Sep; 19(17):5231-7. PubMed ID: 21820903
[TBL] [Abstract][Full Text] [Related]
38. The conformational musings of a medicinal chemist.
Finch H
Drug Discov Today; 2014 Mar; 19(3):320-5. PubMed ID: 24184532
[TBL] [Abstract][Full Text] [Related]
39. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
Richardson TI; Norman BH; Lugar CW; Jones SA; Wang Y; Durbin JD; Krishnan V; Dodge JA
Bioorg Med Chem Lett; 2007 Jul; 17(13):3570-4. PubMed ID: 17485205
[TBL] [Abstract][Full Text] [Related]
40. Effect of crystal freezing and small-molecule binding on internal cavity size in a large protein: X-ray and docking studies of lipoxygenase at ambient and low temperature at 2.0 A resolution.
Skrzypczak-Jankun E; Borbulevych OY; Zavodszky MI; Baranski MR; Padmanabhan K; Petricek V; Jankun J
Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):766-75. PubMed ID: 16790932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]